Epirubicin regimen cuts risk of death in premenopausal women with early breast cancer.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017697:Premenopause; D015996:Survival Rate
D003561:Cytarabine; D015251:Epirubicin; D003520:Cyclophosphamide